Recent Finacing
Recent Raise
Envoy Therapeutics uses its bacTRAP® platform to identify circuit-selective drug targets and develop oral receptor-modulating therapeutics for Parkinson’s disease and other neurological and psychiatric disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors